Nebion will be present at the joint conference ISMB/ECCB from July 21-25 in Basel, Switzerland. Meet Nebion statistician Jean-Marie Droz or our CEO, Philip Zimmermann, to discuss in more detail what Nebion is developing in cell type deconvolution, blood transcriptome analysis and single-cell RNA-Seq.